CPW
KRTX

Catalyst Private Wealth’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Catalyst Private Wealth’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-77,855
Closed -$24.6M – 84
2023
Q4 		$24.6M Buy
77,855
+56,018
+257% +$10.9M 11.57% 2
2023
Q3 		$3.69M Hold
21,837
– – 2.18% 10
2023
Q2 		$4.74M Hold
21,837
– – 2.97% 7
2023
Q1 		$3.97M Hold
21,837
– – 2.74% 7
2022
Q4 		$4.29M Buy
21,837
+7,361
+51% +$1.58M 3.49% 5
2022
Q3 		$3.26M Sell
14,476
-10,500
-42% -$2.13M 2.46% 7
2022
Q2 		$3.16M Hold
24,976
– – 2.24% 10
2022
Q1 		$3.17M Hold
24,976
– – 1.58% 13
2021
Q4 		$3.27M Buy
24,976
+6,970
+39% +$901K 1.41% 10
2021
Q3 		$2.2M Buy
18,006
+5,000
+38% +$577K 0.94% 11
2021
Q2 		$1.48M Hold
13,006
– – 0.82% 13
2021
Q1 		$1.56M Hold
13,006
– – 1.1% 12
2020
Q4 		$1.32M Buy
13,006
+8,000
+160% +$741K 1.16% 11
2020
Q3 		$387K Buy
+5,006
New +$427K 0.38% 33

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Catalyst Private Wealth's KRTX Position: Q1 2024 in Review

Catalyst Private Wealth sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 77,855 shares — an estimated $24.6M sold.

Catalyst Private Wealth first reported a position in KRTX in Q3 2020 and held it in 14 quarters. The position peaked at $24.6M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Catalyst Private Wealth reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Catalyst Private Wealth sold 77,855 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $24.6M.
  • Catalyst Private Wealth first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2020 and held it in 14 quarters.
  • Catalyst Private Wealth's Karuna Therapeutics, Inc. Common Stock position peaked at $24.6M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Catalyst Private Wealth's 13F filing for Q1 2024, filed 11 Apr 2024.